hotspot -WSS

hotspot

author：Wikipedia 2025-09-29 21:27:35 - browse：4

portrait of Jennifer Adair -- coverage from STAT — Jennifer Adair develops scalable, low cost gene therapies at the Fred Hutchinson Cancer Center and helped found the Global Gene Therapy Initiative. Fred Hutch News Service

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world.

These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and then slowly leak out to low- and middle-income countries, many years later. In the case of gene therapy, that means countries most affected by a disease such as sickle cell may wait decades to access a curative therapy.

For the last few years, a handful of researchers in the U.S. and around the world have tried to find ways of ensuring global access to these technologies. In 2020, they formed the Global Gene Therapy Initiative, with an initial goal of setting up a gene therapy clinical trial for a hemoglobinopathy — such as a disease like sickle cell or beta thalassemia — or HIV in two different low- and middle-income countries by 2024.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Questions loom on AstraZeneca cancer drug as safety concerns ebb

entertainment

WSS

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Doctors' information doesn't help them choose wisely when sick

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Medical mystery: When a cough is not just a cough

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Medicare threatens to cut off funding for HCA's Mission hospital

Guidelines to prevent youth baseball injuries need more muscle

CZI to create biohub to build anti

Affirmative action in medical school literally saved lives

Medical mystery: When a cough is not just a cough

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

'Revelatory' study finds a smoking impact that remains after quitting

At least 13 dead in Texas as scorching temps continue

STAT Summit: The economic case for universal basic health care

entertainment

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Key House Republican on health care plans exit from Congress

How digital tools helped lower hypertension in marginalized patients

STAT Summit: The economic case for universal basic health care

To avoid data mishandling cases, universities eye AI and other tools

Robert F. Kennedy is pitching centrism on health, even on abortion

hotspot

entertainment

focus

entertainment